Pharmacokinetics, pharmacodynamics and safety of oral formulation (CG‐750) of ivaltinostat, a histone deacetylase inhibitor, compared to IV formulation (CG‐745)
Article in British Journal of Clinical Pharmacology (January 2024)
The most recent citing publications are shown below. View all 34 publications that cite this research output on Dimensions.
Synergistic effect of docetaxel combined with a novel multi-target inhibitor CUDC-101 on inhibiting human prostate cancer
Article in Pathology - Research and Practice (November 2023)
A phase I/II study of ivaltinostat combined with gemcitabine and erlotinib in patients with untreated locally advanced or metastatic pancreatic adenocarcinoma
Article in International Journal of Cancer (June 2022)